Shareholders, financial analysts, representatives of banks, brokerage firms and other investment professionals should address inquiries concerning Novo Nordisk and its businesses to the company's Investor Relations offices:
Mogens Thorsager Jensen Head of Investor Relations Vice President Novo Alle 2880 Bagsværd Denmark Tel.: +45 4442 7945 Fax: +45 4443 6633 e-mail: mtj@novonordisk.com
Christian Qvist Frandsen Investor Relations Manager Novo Alle 2880 Bagsværd Denmark Tel: +45 4443 5182 Fax: +45 4443 6633 e-mail: cqfr@novonordisk.com
Mads Veggerby Lausten
Investor Relations Manager 100 College Road West Princeton, New Jersey 08540 USA Tel.: +1 609 919 7937 Fax: +1 609 987 3095 e-mail: mlau@novonordisk.com
Elsebeth S. Christiansen
Investor Relations Assistant Novo Alle 2880 Bagsværd Denmark Tel.: +45 4443 1887 Fax: +45 4443 6633 e-mail: echr@novonordisk.com
This page has been assessed by PricewaterhouseCoopers as part of its assessment of Novo Nordisk’s statement that it reports ‘in accordance’ with GRI. Please refer to Audit and assurance for a full description of the nature of assurance offered.
